Search results for "Thrombolysi"

showing 10 items of 120 documents

Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral …

2017

Abstract Background Patients with peripheral artery disease (PAD) undergoing a lower-extremity revascularization are at heightened risk for ischemic cardiac and limb events. Although intensification of antithrombotic therapy after revascularization has demonstrated benefit in coronary disease populations, this approach has not been well studied or shown consistent benefit in PAD. Recent trial evidence demonstrated that a treatment strategy of rivaroxaban added to background antiplatelet therapy reduced ischemic risk in patients following recent acute coronary syndromes, as well as in patients with stable atherosclerotic vascular disease. Whether these benefits extend to the population of pa…

Malemedicine.medical_specialtymedicine.medical_treatmentPopulation030204 cardiovascular system & hematologyRevascularizationlaw.invention03 medical and health sciencesPeripheral Arterial Disease0302 clinical medicineRandomized controlled trialDouble-Blind MethodRivaroxabanlawInternal medicinemedicineHumans030212 general & internal medicineMyocardial infarctioneducationRivaroxabaneducation.field_of_studyAspirinDose-Response Relationship Drugbusiness.industryEndovascular ProceduresThrombolysisMiddle Agedmedicine.diseaseClinical trialTreatment OutcomeLower ExtremityCardiologyPurinergic P2Y Receptor AntagonistsPlatelet aggregation inhibitorDrug Therapy CombinationFemaleCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation Inhibitorsmedicine.drugFactor Xa InhibitorsFollow-Up StudiesAmerican heart journal
researchProduct

Spontaneous splenic rupture after thrombolysis for ischemic stroke.

2015

Spontaneous spleen rupture with no recent report of trauma is an extremely rare and life-threatening cause of intraperitoneal hemorrhage.We present the first case of an atraumatic pathological splenic rupture following alteplase thrombolysis for ischemic stroke.

Malemedicine.medical_specialtymedicine.medical_treatmentSpleen ruptureTissue plasminogen activatorFibrinolytic AgentsInternal medicinemedicineHumansThrombolytic TherapyPathologicalStrokeThrombectomyRupture Spontaneousbusiness.industryGeneral MedicineThrombolysisSplenic RuptureMiddle Agedmedicine.diseaseStrokeTissue Plasminogen ActivatorIschemic strokeEmergency MedicineCardiologybusinessFibrinolytic agentmedicine.drugThe American journal of emergency medicine
researchProduct

Combined medical and mechanical recanalization in acute myocardial infarction

1985

A technique of combined medical and mechanical recanalization was employed in 96 patients with acute transmural myocardial infarction. The mean time between onset of symptoms and admission to hospital was 170 +/- 65 min (X +/- SD). After 10 +/- 16 min, 250,000 U streptokinase was administered intravenously for 20 min. Intracoronary thrombolysis was commenced within 38 +/- 14 min. First coronary angiograms demonstrated reperfusion, an open vessel in 25/96 patients (26%). In 15/71 patients (21%) reperfusion occurred during thrombolysis therapy, before mechanical recanalization could be performed. Recanalization was achieved mechanically in 37/71 patients (52%) with occluded coronary vessels. …

Malemedicine.medical_specialtymedicine.medical_treatmentStreptokinaseMyocardial InfarctionCoronary DiseaseAnterior myocardial infarctionElectrocardiographyRecurrenceCoronary CirculationInternal medicinemedicineHumansInfusions ParenteralStreptokinaseMyocardial infarctionAgedChemotherapybusiness.industryHemodynamicsArrhythmias CardiacStroke VolumeThrombolysisMiddle Agedmedicine.diseaseCombined Modality TherapyMyocardial ContractionPeripheralCoronary vesselCardiologyFemaleCardiology and Cardiovascular MedicinebusinessAngioplasty Balloonmedicine.drugIntracoronary thrombolysisCatheterization and Cardiovascular Diagnosis
researchProduct

Outcomes after extracorporeal membrane oxygenation for the treatment of high-risk pulmonary embolism: a multicentre series of 52 cases

2018

International audience; Aims The role of extracorporeal membrane oxygenation (ECMO) remains ill defined in pulmonary embolism (PE). We investigated outcomes in patients with high-risk PE undergoing ECMO according to initial therapeutic strategy. Methods and results From 01 January 2014 to 31 December 2015, 180 patients from 13 Departments in nine centres with high-risk PE were retrospectively included. Among those undergoing ECMO, we compared characteristics and outcomes according to adjunctive treatment strategy (systemic thrombolysis, surgical embolectomy, or no reperfusion therapy). Primary outcome was all-cause 30-day mortality. Secondary outcome was 90-day major bleeding. One hundred a…

Malemedicine.medical_specialtymedicine.medical_treatment[SDV]Life Sciences [q-bio]Embolectomy030204 cardiovascular system & hematologyEmbolectomy03 medical and health sciences0302 clinical medicineReperfusion therapyExtracorporeal Membrane OxygenationFibrinolysismedicineExtracorporeal membrane oxygenationHumans030212 general & internal medicineRetrospective Studiesbusiness.industryRetrospective cohort studyThrombolysisMiddle Agedmedicine.diseasePrognosisPulmonary embolismSurgerySurvival Rate[SDV] Life Sciences [q-bio]surgical procedures operativeEchocardiographyAdjunctive treatmentFemaleFranceCardiology and Cardiovascular MedicinebusinessPulmonary EmbolismFollow-Up Studies
researchProduct

Intracerebral Hemorrhage and Outcome After Thrombolysis in Stroke Patients Using Selective Serotonin-Reuptake Inhibitors.

2017

Background and Purpose— Selective serotonin-reuptake inhibitors (SSRIs) impair platelet function and have been linked to a higher risk of spontaneous intracerebral hemorrhage—an association that may be augmented by oral anticoagulants (OAC). We aimed to assess whether preadmission treatment with SSRIs in patients with acute ischemic stroke is associated with post-thrombolysis symptomatic intracerebral hemorrhage (sICH) and functional outcome. Methods— A multicenter retrospective analysis was conducted in prospective registries of patients treated by thrombolysis within 4.5 hours of stroke onset. The association between preadmission treatment with SSRIs and sICH (ECASS II definition [Europe…

Malemedicine.medical_specialtytherapeutic use [Anticoagulants]medicine.medical_treatmentSubgroup analysisepidemiology [Cerebral Hemorrhage]Risk AssessmentCohort Studies03 medical and health sciencesadverse effects [Serotonin Uptake Inhibitors]0302 clinical medicineModified Rankin ScaleInternal medicinemedicineHumansThrombolytic Therapy030212 general & internal medicineddc:610610 Medicine & healthStrokeCerebral HemorrhageAgedRetrospective StudiesAdvanced and Specialized NursingIntracerebral hemorrhageAged 80 and overtherapy [Cerebral Hemorrhage]business.industryAnticoagulantsThrombolysisOdds ratioMiddle Agedmedicine.diseaseadverse effects [Selective Serotonin Reuptake Inhibitors]Prognosisdrug therapy [Stroke]StrokeTreatment OutcomeAnesthesiaConcomitantSerotonin Uptake InhibitorsFemaleNeurology (clinical)Cardiology and Cardiovascular Medicinebusiness030217 neurology & neurosurgerySelective Serotonin Reuptake Inhibitorsepidemiology [Stroke]Cohort study
researchProduct

Effects of a Feedback-Demanding Stroke Clock on Acute Stroke Management: A Randomized Study.

2023

Background and Purpose: This randomized study aimed to evaluate whether the use of a stroke clock demanding active feedback from the stroke physician accelerates acute stroke management. Methods: For this randomized controlled study, a large-display alarm clock was installed in the computed tomography room, where admission, diagnostic work-up, and intravenous thrombolysis occurred. Alarms were set at the following target times after admission: (1) 15 minutes (neurological examination completed); (2) 25 minutes (computed tomography scanning and international normalized ratio determination by point-of-care laboratory completed); and (3) 30 minutes (intravenous thrombolysis started). The resp…

Malemedicine.medical_specialtythrombolysisTime FactorsComputed Tomography Angiographymedicine.medical_treatment610law.inventionBrain IschemiaFeedbackPhysical medicine and rehabilitationRandomized controlled trialFibrinolytic AgentslawmedicineHumansActive feedbackThrombolytic TherapyAcute managementStrokeAcute strokeAgedAdvanced and Specialized NursingAged 80 and overbusiness.industryDisease ManagementThrombolysisMiddle Agedmedicine.diseaseStrokethrombectomyTissue Plasminogen ActivatorFemaleNeurology (clinical)Cardiology and Cardiovascular Medicinebusinessacute managementTomography X-Ray ComputedStroke
researchProduct

Intravenous Thrombolysis in Patients Dependent on the Daily Help of Others Before Stroke

2016

Background and Purpose— We compared outcome and complications in patients with stroke treated with intravenous thrombolysis (IVT) who could not live alone without help of another person before stroke (dependent patients) versus independent ones. Methods— In a multicenter IVT-register–based cohort study, we compared previously dependent (prestroke modified Rankin Scale score, 3–5) versus independent (prestroke modified Rankin Scale score, 0–2) patients. Outcome measures were poor 3-month outcome (not reaching at least prestroke modified Rankin Scale [dependent patients]; modified Rankin Scale score of 3–6 [independent patients]), death, and symptomatic intracranial hemorrhage. Unadjusted an…

Malemedicine.medical_treatment030204 cardiovascular system & hematologylaw.inventionCohort Studies0302 clinical medicineRandomized controlled triallawModified Rankin ScaleActivities of Daily Living80 and overThrombolytic TherapyRegistriesStrokeriskAged 80 and overpreexisting disabilityMedicine (all)survivorsThrombolysisMiddle Aged3. Good healthStrokeTreatment OutcomeInfusions intravenous; Intracranial hemorrhages; Outcome assessment (health care); Stroke; Survivors; Administration Intravenous; Aged; Aged 80 and over; Cohort Studies; Female; Humans; Logistic Models; Male; Middle Aged; Stroke; Treatment Outcome; Activities of Daily Living; Independent Living; Registries; Thrombolytic Therapy; Medicine (all); Neurology (clinical); Cardiology and Cardiovascular Medicine; Advanced and Specialized Nursingcontrolled-trialAdministration[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Administration IntravenousFemaleIndependent Livingacute ischemic-strokehemorrhageCardiology and Cardiovascular MedicineCohort studymedicine.medical_specialtyintracranial hemorrhagesstatinsscale03 medical and health sciencesInternal medicinemedicineHumansDementiaAgedoutcome assessment (health care)Advanced and Specialized Nursingreliabilitybusiness.industryOdds ratiomedicine.diseaseConfidence intervalinfusionsSurgeryLogistic Models[ SDV.NEU ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]intravenousiv thrombolysisNeurology (clinical)business030217 neurology & neurosurgeryStroke
researchProduct

The risk of intravenous thrombolysis-induced intracranial hemorrhage in Taiwanese patients with unruptured intracranial aneurysm.

2017

Background The presence of an intracranial aneurysm is contraindicated to recombinant tissue plasminogen activator (r-tPA) treatment for acute ischemic stroke. However, it is difficult to exclude asymptomatic intracranial aneurysms by using conventional, noncontrast head computed tomography (CT), which is the only neuroimaging suggested before r-tPA. Recent case reports and series have shown that administering r-tPA to patients with a pre-existing aneurysm does not increase the bleeding risk. However, Asians are known to have a relatively higher bleeding risk, and little evidence is available regarding the risk of using r-tPA on Asian patients with intracranial aneurysms. Methods Medical re…

Malemedicine.medical_treatmentlcsh:MedicineCardiovascular Medicine030204 cardiovascular system & hematologyPathology and Laboratory MedicineVascular MedicineMagnetic resonance angiographyDiagnostic Radiology0302 clinical medicineRisk FactorsMedicine and Health SciencesMedicineThrombolytic TherapyCardiovascular ImagingInfusions Intravenouslcsh:ScienceTomographyStrokeAged 80 and overMultidisciplinarymedicine.diagnostic_testRadiology and ImagingMedical recordAngiographyArteriesThrombolysisStrokeHemorrhagic StrokeNeurologyTissue Plasminogen Activatorcardiovascular systemFemaleRadiologyAnatomymedicine.symptomAneurysmsIntracranial HemorrhagesResearch Articlemedicine.medical_specialtyImaging TechniquesCerebrovascular DiseasesTaiwanHemorrhageNeuroimagingResearch and Analysis MethodsAsymptomatic03 medical and health sciencesSigns and SymptomsAneurysmDiagnostic MedicineHumansVascular Diseasescardiovascular diseasesIschemic StrokeAgedbusiness.industrylcsh:RBiology and Life SciencesIntracranial AneurysmMagnetic resonance imagingCerebral Arteriesmedicine.diseaseComputed Axial TomographyAngiographyCardiovascular AnatomyBlood Vesselslcsh:QbusinessMagnetic Resonance Angiography030217 neurology & neurosurgeryNeurosciencePLoS ONE
researchProduct

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ER…

2020

Guidelines summarize and evaluate available evidence with the aim of assisting health professionals in proposing the best management strategies for an individual patient with a given condition. Guidelines and their recommendations should facilitate decision making of health professionals in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate.

ORAL ANTICOAGULANT-THERAPYdiagnosis[SDV]Life Sciences [q-bio]Medizin030204 cardiovascular system & hematologyEmbolectomyGuidelineRECURRENT VENOUS THROMBOEMBOLISM0302 clinical medicinePregnancyDaily practiceDiagnosisPulmonary medicineVenous thrombosisPulmonary MedicineThrombolytic TherapyDEEP-VEIN THROMBOSISDisease management (health)Societies MedicalComputingMilieux_MISCELLANEOUShealth care economics and organizationsRisk assessmentddc:616RIGHT-VENTRICULAR DYSFUNCTIONDisease ManagementShockMOLECULAR-WEIGHT HEPARINThrombolysishumanities3. Good healthPulmonary embolismEuropeAnticoagulation; Biomarkers; Diagnosis; Dyspnoea; Echocardiography; Embolectomy; Guidelines; Heart failure; Pregnancy; Pulmonary embolism; Right ventricle; Risk assessment; Shock; Thrombolysis; Treatment; Venous thromboembolism; Venous thrombosismedicine.veinEchocardiographyAcute DiseaseRight ventricleMedical emergencyCardiology and Cardiovascular MedicineRisk assessmentguidelines; pulmonary embolism; venous thrombosis; shock dyspnoea; heart failure: right ventricle: diagnosis; risk assessment: echocardiography; biomarkers; treatment; anticoagulation; thrombolysis; pregnancy; venous thromboembolism; embolectomyDiagnosiVenous thromboembolismthrombolysiseducationCardiologyMEDLINEThrombolysiHeart failure610 Medicine & healthGuidelinesInferior vena cava2705 Cardiology and Cardiovascular MedicineEXTRACORPOREAL MEMBRANE-OXYGENATION03 medical and health sciencesAnticoagulationMedicalDyspnoeamedicineHumansRIGHT HEART THROMBIVENTILATION-PERFUSION SCINTIGRAPHYshock dyspnoeaHealth professionalsbusiness.industryINFERIOR VENA-CAVA10031 Clinic for Angiologyheart failure: right ventricle: diagnosisPulmonary embolismAnticoagulantsbiomarkersrisk assessment: echocardiography030229 sport sciencesBiomarkermedicine.diseaseTreatmentINHALED NITRIC-OXIDESocietiesbusinessBiomarkers
researchProduct

Editor's Choice – European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis

2021

European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis

ORAL ANTICOAGULANT-THERAPYmedicine.medical_specialtyELASTIC COMPRESSION STOCKINGSMEDLINEED AMERICAN-COLLEGEInferior vena cavaCATHETER-DIRECTED THROMBOLYSISBlood vessel prosthesisdeep-vein-thrombosisHeparin-induced thrombocytopeniamedicineYoung adultUPPER EXTREMITY DEEPbusiness.industryINFERIOR VENA-CAVAHEPARIN-INDUCED-THROMBOCYTOPENIAsilent pulmonary-embolismMOLECULAR-WEIGHT HEPARINVascular surgerymedicine.diseaseSurgeryClinical PracticeVenous thrombosismedicine.veinSurgeryCardiology and Cardiovascular MedicinebusinessEuropean Journal of Vascular and Endovascular Surgery
researchProduct